Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
9.39
-0.17 (-1.78%)
Apr 1, 2025, 4:00 PM EDT - Market closed
Assembly Biosciences Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Assembly Biosciences stock have an average target of 33, with a low estimate of 31 and a high estimate of 35. The average target predicts an increase of 251.44% from the current stock price of 9.39.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Assembly Biosciences stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Strong Buy Initiates $31 | Strong Buy | Initiates | $31 | +230.14% | Mar 25, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 24, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 27, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 24, 2024 |
Jefferies | Jefferies | Hold → Strong Buy Upgrades $2 → $35 | Hold → Strong Buy | Upgrades | $2 → $35 | +272.74% | Sep 20, 2024 |
Financial Forecast
Revenue This Year
31.61M
from 28.52M
Increased by 10.82%
Revenue Next Year
24.86M
from 31.61M
Decreased by -21.33%
EPS This Year
-6.42
from -6.69
EPS Next Year
-9.23
from -6.42
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 35.4M | 32.1M | 124.7M |
Avg | 31.6M | 24.9M | 60.6M |
Low | 27.7M | 17.8M | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 24.1% | 1.6% | 401.5% |
Avg | 10.8% | -21.3% | 143.6% |
Low | -2.9% | -43.6% | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -6.60 | -9.50 | -12.67 | ||
Avg | -6.42 | -9.23 | -12.31 | ||
Low | -6.16 | -8.87 | -11.83 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.